0001104659-22-020353.txt : 20220211 0001104659-22-020353.hdr.sgml : 20220211 20220211150330 ACCESSION NUMBER: 0001104659-22-020353 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220211 DATE AS OF CHANGE: 20220211 EFFECTIVENESS DATE: 20220211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Opportunity Management V, LLC CENTRAL INDEX KEY: 0001792207 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-21821 FILM NUMBER: 22619905 BUSINESS ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001792207 XXXXXXXX 12-31-2021 12-31-2021 false Foresite Capital Opportunity Management V, LLC

900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939

13F HOLDINGS REPORT 028-21821 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 02-11-2022 0 9 149164 INFORMATION TABLE 2 infotable.xml Adicet Bio, Inc. COM 007002108 2973 170000 SH SOLE 170000 0 0 Compass Therapeutics, Inc. COM 20454B104 3487 1100000 SH SOLE 1100000 0 0 Cullinan Oncology, Inc. COM 230031106 5879 381002 SH SOLE 381002 0 0 Cue Health Inc. COM 229790100 20478 1527103 SH SOLE 1527103 0 0 Gemini Therapeutics, Inc. COM 36870G105 7086 2435125 SH SOLE 2435125 0 0 Kinnate Biopharma Inc. COM 49705R105 5168 291667 SH SOLE 291667 0 0 Pardes Biosciences Inc COM 69945Q105 85571 5227307 SH SOLE 5227307 0 0 Quantum-Si Incorporated COM CL A 74765K105 12577 1598125 SH SOLE 1598125 0 0 Theseus Pharmaceuticals, Inc. COM 88369M101 5945 468820 SH SOLE 468820 0 0